目的 調(diào)查天津市兒童醫(yī)院2014年9月小兒肺熱咳喘口服液的處方應用情況。方法 隨機抽取天津市兒童醫(yī)院2014年9月門急診含有小兒肺熱咳喘口服液的處方共300張,對小兒肺熱咳喘口服液的應用情況和合理性進行總結(jié)分析。結(jié)果 小兒肺熱咳喘口服液主要用于小兒肺炎、支氣管炎、上呼吸道感染的治療。開具小兒肺熱咳喘口服液的處方以單獨用藥為主,占處方總數(shù)的77.3%。聯(lián)合用藥以聯(lián)用祛痰劑和解表劑為主,分別占聯(lián)用總處方數(shù)的35.3%、25.0%。開具該藥的科室以內(nèi)科門診為主,共占處方總數(shù)的56.3%。小兒肺熱咳喘口服液的不合理使用主要包括不規(guī)范和不適宜處方兩種,分別以臨床診斷不規(guī)范和用法、用量不適宜為主,占不合理處方總數(shù)的30.9%、27.3%。結(jié)論 天津市兒童醫(yī)院小兒肺熱咳喘口服液的使用基本合理,但仍需進一步提高處方質(zhì)量,規(guī)范臨床合理用藥。

Objective To investigate the prescription application of Xiao'er Feire Kechuan Oral Solution (XFKOS) in Tianjin Children's Hospital in September 2014. Methods By randomly taking 300 prescriptions of XFKOS in outpatient and emergency departments of Tianjin Children's Hospital in September 2014, the application and rationality of Xiao'er Feire Kechuan Oral Solution was reviewed and analyzed. Results XFKOS was mainly used for treating infantile pneumonia, bronchitis, and upper respiratory tract infection. The prescriptions of XFKOS were mainly used alone, which accounted for 77.3% of all the prescriptions. The combined use of the drugs were mostly combined with expectorant agents and reconciliatory agents, which accounted for 35.3% and 25.0% of all the combined prescriptions. The drug was chiefly prescribed by the outpatient department of internal medicine, which accounted for 56.3% of all the prescriptions. Irrational usage of XFKOS mainly included non-standard and inappropriate prescriptions. Most of irrational prescriptions were that clinical diagnosis was abnormal and usage and dosage was indisposition, which accounted for 30.9% and 27.3%, respectively. Conclusion The application of XFKOS in Tianjin Children's Hospital is rational on the whole, but it is necessary to further improve the quality of prescriptions, and standardize the rational use in clinic.